Elevated liver enzymes often pose a diagnostic dilemma for clinicians, due to their non-specific nature and wide array of potential etiologies. This article aims to provide a comprehensive approach to decipher this clinical conundrum.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are the most commonly assessed liver enzymes. Their elevation is suggestive of hepatocellular injury. However, the degree of elevation does not necessarily correlate with the severity of liver damage.
Common causes include viral hepatitis, alcohol-related liver disease, non-alcoholic fatty liver disease, and drug-induced liver injury. Less common causes include autoimmune hepatitis, hemochromatosis, Wilson's disease, and alpha-1 antitrypsin deficiency.
A thorough history and physical examination should be the initial step. If the cause is not apparent, a systematic approach should be adopted. This includes ruling out common causes first, followed by screening for less common causes if initial investigations are inconclusive. Imaging studies and liver biopsy may be required in certain situations.
Management largely depends on the underlying cause. Lifestyle modifications and abstinence from alcohol are often recommended. Regular follow-up with liver function tests is essential to monitor response to treatment and progression of disease. In cases of persistent unexplained elevation, referral to a hepatologist may be necessary.
Elevated liver enzymes present a diagnostic challenge due to the broad differential diagnosis. A systematic and comprehensive approach can help clinicians in making an accurate diagnosis and initiating appropriate management. Continuous medical education and staying updated with the latest research are key to overcoming this diagnostic dilemma.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation